KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to 9.4%.

  • Exact Sciences' EBITDA Margin rose 1134300.0% to 9.4% in Q4 2025 from the same period last year, while for Dec 2025 it was 6.35%, marking a year-over-year increase of 316600.0%. This contributed to the annual value of 6.35% for FY2025, which is 316600.0% up from last year.
  • Per Exact Sciences' latest filing, its EBITDA Margin stood at 9.4% for Q4 2025, which was up 1134300.0% from 3.0% recorded in Q3 2025.
  • Exact Sciences' 5-year EBITDA Margin high stood at 1.09% for Q3 2023, and its period low was 122.84% during Q4 2024.
  • For the 5-year period, Exact Sciences' EBITDA Margin averaged around 26.05%, with its median value being 15.16% (2024).
  • As far as peak fluctuations go, Exact Sciences' EBITDA Margin plummeted by -1123500bps in 2024, and later surged by 1134300bps in 2025.
  • Quarter analysis of 5 years shows Exact Sciences' EBITDA Margin stood at 46.74% in 2021, then skyrocketed by 54bps to 21.5% in 2022, then soared by 51bps to 10.49% in 2023, then tumbled by -1071bps to 122.84% in 2024, then surged by 92bps to 9.4% in 2025.
  • Its EBITDA Margin was 9.4% in Q4 2025, compared to 3.0% in Q3 2025 and 0.26% in Q2 2025.